Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00467
Species: Homo sapiens
Position : chr13:42939000-42967000
Year: 2018
Title: Multiple functional variants at 13q14 risk locus for osteoporosis regulate RANKL expression through long-range super-enhancer
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: osteosarcoma
PMID:  29528523
MONDO: MONDO:0005087
Tissue: Bone
Tissue Ontology ID: UBERON:0001474
Cell Source: U2-OS osteosarcoma osteoblastic cells
CVCL ID: CVCL_0042
Cell Type: osteosarcoma cell
Cell Ontology ID: CL:0000082
Experiment Type: Enhancer activity assay, Chromatin interaction assay, Functional perturbation assay
High Throughput Method: Hi-C, ChIP-seq, RNA-seq
Low Throughput Method: qRT-PCR, and ChIP-qPCR
About Target Gene
Target gene : RANKL
About TF
TF name :
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 13 found
Enhancer ID Position Tissue Cell Disease
E_00465 chr13:42939000-42967000 Blood B lymphoblastoid cell --
E_00466 chr13:42939000-42967000 Bone Marrow CD34-positive hematopoietic stem cell --
E_00468 chr13:42940000-42940969 Bone osteosarcoma cell osteosarcoma
E_00469 chr13:42940000-42940969 Blood B lymphoblastoid cell --
E_00470 chr13:42955000-42955967 Bone osteosarcoma cell osteosarcoma
E_00471 chr13:42955000-42955967 Blood B lymphoblastoid cell --
E_00472 chr13:42955000-42955967 Bone Marrow CD34-positive hematopoietic stem cell --
E_00473 chr13:42956000-42956832 Bone osteosarcoma cell osteosarcoma
E_00474 chr13:42956000-42956832 Blood B lymphoblastoid cell --
E_00475 chr13:42956000-42956832 Bone Marrow CD34-positive hematopoietic stem cell --
E_00476 chr13:42965000-42965891 Bone osteosarcoma cell osteosarcoma
E_00477 chr13:42965000-42965891 Blood B lymphoblastoid cell --
E_00478 chr13:42965000-42965891 Bone Marrow CD34-positive hematopoietic stem cell --
Expression of Target Genes for the Enhancer